WWBP Worldwide Biotech & Pharmaceutical Company featured news, full reports, and detailed charts
Worldwide Biotech & Pharmaceutical Company (WWBP/WWBP.OB) Wrap Up:
Worldwide Biotech & Pharmaceutical Company, a biopharmaceutical company, together with its subsidiaries, specializes in the development and marketing of viruses/viral vectors, bio-medicines, external diagnostic reagents, prophylactic vaccines for humans, and oral dosage forms of traditional Chinese medicine. It also engages in developing a hepatitis C vaccine. The company’s products include hepatitis C virus (HCV) produced in-vitro; Elisa kits for HCV antibody detection; anti-HCV medicines; and HCV human vaccines. It also engages in the research, development, and manufacture of over-the-counter traditional Chinese medicines, synthetic medicines, and functional foods; and distribution of medi...Worldwide Biotech & Pharmaceutical Company (WWBP:OTC Bulletin Board Market)
Snapshot of Worldwide Biotech & Pharmaceutical Company (WWBP)
|
OPEN
--
|
PREVIOUS CLOSE
$0.02
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
07/2/09 - $0.09
|
52 WEEK LOW
06/4/09 - $0.01
|
|
|
MARKET CAP
808.7K
|
AVERAGE VOLUME 3 mo
8.6K
|
|
|
DILUTED EPS TTM
$-0.04
|
SHARES OUTSTANDING
53.9M
|
|
|
WWBP Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
WWBP Top Compensated Officers
Executives, Board Directors
Key developments for Worldwide Biotech & Pharmaceutical Company (WWBP)
Worldwide Biotech & Pharmaceutical Company announced earnings results for the first quarter ended March 31, 2009. For the quarter, the company reported net loss (excluding non-controlling interest) of $194,360. In contrast, the company posted a net loss (excluding non-controlling interest) of $204,323 for the same quarter in the previous year.
Worldwide Biotech & Pharmaceutical Company filed its 10-K on March 31, 2009 for the period ending December 31, 2008. In this report its auditor, Kempisty & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
On 08/13/2008, Worldwide Biotech & Pharmaceutical Company announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
WWBP Competitors
| Company | Last | Change | |
| No competitor information is available for WWBP. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | WWBP | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 9.0x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
WWBP |
||
WWBP transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||